Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer

Cancer Research

Volumn 67, Issue 4, 2007, Pages 1618-1625

  Turner, David P ^a   Moussa, Omar ^a   Sauane, Moira ^b   Fisher, Paul B ^b   Watson, Dennis K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PROSTATE DERIVED ETS FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL POLARITY; CELL STIMULATION; DOWN REGULATION; FOCAL ADHESION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM;

ACTINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSFECTION;

EID: 33847726936     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2913     Document Type: Article

References (42)

1. Sporn MB. The war on cancer. Lancet 1996;347:1377-81.
2. Liotta LA, Stetler-Stephenson WG. Principles of molecular cell biology of cancer: cancer metastasis. In: Devita V, Hellman S, Rosenberg SA, editors. Cancer: principles and practices of oncology. Philadelphia (PA): JB Lippincott Co.; 1993.
3. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003;3:362-74.
4. Hunter KW. Host genetics and tumour metastasis. Br J Cancer 2004;90:752-5.
5. Watson DK, Seth A. ETS gene family. In: Jenkins J, Reddy EP, editors. Oncogene reviews. London: Nature Publishing Group; 2000. p. 6393-548.
6. Watson DK, Li R, Sementchenko VI, Mavrothalassitis G, Seth A. The ETS genes. In: Bertino JR, editor. Encyclopedia of cancer. San Diego: Academic Press; 2001. p. 189-96.
7. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003;2:29-49.
8. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene 2003;303:11-34.
9. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005;41:2462-78.
10. Watabe T, Yoshida K, Shindoh M, et al. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 1998;77:128-37.
11. Buggy Y, Maguire TM, McGreal G, et al. Over-expression of the Ets-1 transcription factor in human breast cancer. Br J Cancer 2004;91:1308-15.
12. Buggy Y, Maguire TM, McDermott E, Hill AD, O'Higgins N, Duffy MJ. Ets2 transcription factor in normal and neoplastic human breast tissue. Eur J Cancer 2006;42:485-91.
13. Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 2001;194:43-50.
14. Eccles SA. The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis. J Mammary Gland Biol Neoplasia 2001;6:393-406.
15. Benz CC, O'Hagan RC, Richter B, et al. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 1997;15:1513-25.
16. Bieche I, Tozlu S, Girault I, et al. Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1, and CGB expression. Carcinogenesis 2004;25:405-11.
17. Bosc DG, Goueli BS, Janknecht R. HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 2001;20:6215-24.
18. Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology 2001;61 Suppl 2:1-13.
19. Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res 2003;63:4626-31.
20. Nozawa M, Yomogida K, Kanno N, et al. Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells. Cancer Res 2000;60:1348-52.
21. Gopalkrishnan RV, Christiansen KA, Goldstein NI, DePinho RA, Fisher PB. Use of the human EF-1α promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res 1999;27:4775-82.
22. Bartsch JE, Staren ED, Appert HE. Adhesion and migration of extracellular matrix-stimulated breast cancer. J Surg Res 2003;110:287-94.
23. Windler-Hart SL, Chen KY, Chenn A. A cell behavior screen: identification, sorting, and enrichment of cells based on motility. BMC Cell Biol 2005;6:14-23.
24. Ponti A, Machacek M, Gupton SL, Waterman-Storer CM, Danuser G. Two distinct actin networks drive the protrusion of migrating cells. Science 2004;305:1782-6.
25. Schafer DA. Cell biology: barbed ends rule. Nature 2004;430:734-5.
26. Condeelis JS, Wyckoff JB, Bailly M, et al. Lamellipodia in invasion. Semin Cancer Biol 2001;11:119-28.
27. Wood W, Martin P. Structures in focus - filopodia. Int J Biochem Cell Biol 2002;34:726-30.
28. Faix J, Rottner K. The making of filopodia. Curr Opin Cell Biol 2006;18:18-25.
29. Wells A, Gupta K, Chang P, Swindle S, Glading A, Shiraha H. Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc Res Tech 1998;43:395-411.
30. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005;5:505-15.
31. Gupton SL, Waterman-Storer CM. Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 2006;125:1361-74.
32. Ghadersohi A, Pan D, Fayazi Z, Hicks DG, Winston JS, Li F. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo. Breast Cancer Res Treat [serial on the Internet]. 2006 Aug: [12 p]. Available from: http://www.springerlink.com/ content/9v16167ku650l147.
33. Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS. Novel role for PDEF in epithelial cell migration and invasion. Cancer Res 2005;65:11572-80.
34. Tsujimoto Y, Nonomura N, Takayama H, et al. Utility of immunohistochemical detection of prostate-specific Ets for the diagnosis of benign and malignant prostatic epithelial lesions. Int J Urol 2002;9:167-72.
35. Ghadersohi A, Sood AK. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin Cancer Res 2001;7:2731-8.
36. Ghadersohi A, Odunsi K, Lele S, et al. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules. Oncol Rep 2004;11:453-8.
37. Pantaloni D, Le Clainche C, Carlier MF. Mechanism of actin-based motility. Science 2001;292:1502-6.
38. Danuser G. Coupling the dynamics of two actin networks - new views on the mechanics of cell protrusion. Biochem Soc Trans 2005;33:1250-3.
39. Mogilner A. On the edge: modeling protrusion. Curr Opin Cell Biol 2006;18:32-9.
40. Bailly M, Yan L, Whitesides GM, Condeelis JS, Segall JE. Regulation of protrusion shape and adhesion to the substratum during chemotactic responses of mammalian carcinoma cells. Exp Cell Res 1998;241:285-99.
41. Wehrle-Haller B, Imhof B. The inner lives of focal adhesions. Trends Cell Biol 2002;12:382-9.
42. Zamir E, Geiger B. Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci 2001;114:3583-90.